.:. Consulter > Par domaine > Sciences du Vivant/Médecine humaine et pathologie/Maladies infectieuses .:.

423 documents classés par :  date titre 1er auteur

1 - 2 - 3 - 4 - 5 - 6 - 7 ...

Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study. Champenois K., Cousien A., Cuzin L., Le Vu S., Deuffic-Burban S., Lanoy E., Lacombe K., Patey O., Béchu P., Calvez M. et al BMC Infectious Diseases 13, 1 (2013) 200 [inserm-00822062 - version 1]

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study. Ferrante S. A., Chhatwal J., Brass C., El Khoury A., Poordad F., Bronowicki J.-P., Elbasha E. BMC Infectious Diseases 13, 1 (2013) 190 [inserm-00820362 - version 1]

Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach. Laouénan C., Guedj J., Mentré F. BMC Medical Research Methodology 13, 1 (2013) 60 [inserm-00821560 - version 1]

Age-specific contacts and travel patterns in the spatial spread of 2009 H1N1 influenza pandemic. Apolloni A., Poletto C., Colizza V. BMC Infectious Diseases 13, 1 (2013) 176 [inserm-00820454 - version 1]

Mimiviridae: clusters of orthologous genes, reconstruction of gene repertoire evolution and proposed expansion of the giant virus family. Yutin N., Colson P., Raoult D., Koonin E. Virology Journal 10, 1 (2013) 106 [inserm-00808995 - version 1]

Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine. Beaumont E., Patient R., Hourioux C., Dimier-Poisson I., Roingeard P. Hepatology 57, 4 (2013) 1303-13 [inserm-00812948 - version 1]

Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection. Ferraris P., Beaumont E., Uzbekov R., Brand D., Gaillard J., Blanchard E., Roingeard P. Cellular and Molecular Life Sciences 70, 7 (2013) 1297-306 [inserm-00805157 - version 1]

Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Fall B., Pascual A., Sarr F., Wurtz N., Richard V., Baret E., Diémé Y., Briolant S., Bercion R., Wade B. et al Malaria Journal 12, 1 (2013) 107 [inserm-00803938 - version 1]

gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas. Sagna A. B., Sarr J. B., Gaayeb L., Drame P. M., Ndiath M. O., Senghor S., Sow C. S., Poinsignon A., Seck M., Hermann E. et al Parasites & Vectors 6, 1 (2013) 68 [inserm-00816090 - version 1]

Prospects for prophylactic hepatitis C vaccines based on virus-like particles. Beaumont E., Roingeard P. Human Vaccines and Immunotherapeutics 9, 5 (2013) epub ahead of print [inserm-00812949 - version 1]

1 - 2 - 3 - 4 - 5 - 6 - 7 ...